Bulimia Nervosa denials in California external review

In the California DMHC record, independent physician reviewers decided 98 published external-review cases involving bulimia nervosaand overturned the plan’s denial in 59.2%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.

California DMHC decisions
98
2002–2023
Overturned
59.2%
58 denials reversed

Most-fought treatments for bulimia nervosa

What insurers denied — and how those fights ended.
TreatmentDecisionsOverturned
Residential Treatment27
40.7%
Partial Hospitalization Program26
65.4%
Residential Treatment Center15
66.7%
Typical time to a decision
13 days
Most land between 4 and 21 days
Handled as urgent
39.8%
Expedited when a delay would cause harm

What the reviewers wrote

Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Findings:The physician reviewer found that Nature of Statutory Criteria/Case Summary: The patient’s parent has requested reimbursement and prospective authorization and coverage for residential treatment center (RTC) services (CALOCUS Level 5). The American Academy of Child and Adolescent Psychiatry (AACAP) and American Association for Community Psychiatry (AACP) have unified the Child and Adolescent Level of Care Utilization System (CALOCUS) and the Child and Adolescent Service Intensity Instrument (CASII) into a single instrument, the Child and Adolescent Level of Care/Service Intensity Utilization System (CALOCUS-CASII). This instrument is a standardized tool used to determine the intensity of services needed for children and adolescents, 6-18 years of age, presenting with psychiatric, substance use, medical and/or developmental concerns.
Medical Necessity · 2023 · IMR MN23-38918
Nature of Statutory Criteria/Case Summary: The patient has requested reimbursement for partial hospitalization program (PHP) services and prospective authorization and coverage for residential treatment center (RTC) services. Per the American Society of Addiction Medicine (ASAM) criteria, this patient met Level 3.1 criteria for PHP services and prospective RTC services. ASAM criteria focuses on six dimensions to determine the appropriate level of care, which includes: (1) intoxication and withdrawal potential; (2) biomedical conditions; (3) emotional, behavioral and cognitive conditions; (4) readiness to change; (5) relapse, continued use, or continued problem potential; and (6) recovery environment. For dimension 1, the patient has no signs or symptoms of withdrawal. Thus, she can safely be managed in in a Level 3.1 setting.
Medical Necessity · 2020 · IMR MN20-33474

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
An enrollee who was admitted for partial hospitalization program level of care. In an individual session, she reported cutting on herself one month prior to admission. She is noted to have used alcohol and cannabis. Her body mass index was noted to be. She denied a history of medical problems. The patient had a history of binging and purging as well as food restriction, body checking, and fear of certain foods. A review of the records indicates that the patient was feeling uncomfortable in her own skin. The patient expressed urges to purge or restrict. On, she reported stress regarding meals. On, the patient reported minimal anxiety with transitioning to intensive outpatient program (IOP). Per the records, her diagnoses included major depressive disorder, bulimia nervosa, and anxiety.
Medical Necessity · 2019 · IMR MN19-30389
Nature of Statutory Criteria/Case Summary: An enrollee has requested reimbursement for residential treatment center services provided from. The Health Plan has denied this request indicating that the services at issue were not medically necessary for treatment of the enrollee’s bulimia nervosa. At issue in this case is whether the residential treatment center services at issue, provided, were medically necessary for treatment of the enrollee’s behavioral health condition.The patient was admitted to the residential treatment center after a suicide attempt via overdose. She indicated she took an overdose of antidepressant pills after she was weighed and was unhappy with her weight. On admission she denied any active suicidal or homicidal ideation and did not express any active suicidal ideation during her stay. She did not engage in any self-harm behaviors.
Medical Necessity · 2018 · IMR MN18-29803

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.

Related guide

A diagnosis does not by itself establish treatment intensity. See the separate record for residential, PHP, IOP, inpatient, and withdrawal-management denials: behavioral-health level-of-care evidence guide.

How to use this in your appeal

These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving bulimia nervosa, then check the rights and deadlines that apply to your plan.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Fighting a denial for bulimia nervosa? Use the California record to prepare.

Explain my denial — freeStart my appeal · $39